Literature DB >> 18280810

Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.

P Restituto1, J C Galofré, M J Gil, C Mugueta, S Santos, J I Monreal, N Varo.   

Abstract

OBJECTIVE: Salivary cortisol in the assessment of glucocorticoid related disorders. DESIGN-
METHODS: Serum and salivary cortisol were measured in 189 patients (22 Cushing's syndrome, 67 pseudo-Cushing, 11 Addison's disease, 89 controls) at 8:00 and 24:00 h.
RESULTS: Serum and salivary cortisol correlated in the whole study population (r=0.62, p=0.000). Morning serum and saliva cortisol in Addison's disease were lower than in controls (6.74+/-1.69 vs 22.58+/-1.78 microg/dL, and 0.15+/-0.25 vs 0.67+/-0.12 microg/dL) (p<0.001). Morning serum cortisol was similar in controls and patients with Cushing's syndrome or pseudo-Cushing (22.58+/-1.78 vs 13.96+/-6.02 vs 16.13+/-1.69 microg/dL). Morning serum and salivary cortisol at 8:00 had the same sensitivity to distinguish patients with Addison's disease from healthy controls. 24:00 am serum cortisol in controls (2.61+/-0.20 microg/dL) was lower than in the pseudo-Cushing group (6.53+/-0.77 microg/dL, p<0.001) and in Cushing's syndrome (10.90+/-2.36 microg/dL, p=0.003). 24:00 am salivary cortisol in controls (0.0025+/-0.001 microg/dL) was lower than in patients with Cushing's syndrome (0.58+/-0.11 microg/dL, p<0.001) and those higher than in patient with pseudo-Cushing (0.10+/-0.06 microg/dL, p=0.001). Both salivary cortisol and serum cortisol presented high specificity (82% and 100%) to detect Cushing's syndrome but salivary cortisol higher sensitivity (saliva 88% and serum 50%).
CONCLUSION: Morning salivary cortisol is as good as serum as screening test for patients with Addison's disease and nighttime salivary cortisol is more adequate than serum in the screening of Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280810     DOI: 10.1016/j.clinbiochem.2008.01.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  20 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

Review 2.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 3.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

4.  A venous thromboembolism risk assessment model for patients with Cushing's syndrome.

Authors:  Marialuisa Zilio; Linda Mazzai; Maria Teresa Sartori; Mattia Barbot; Filippo Ceccato; Viviana Daidone; Alessandra Casonato; Graziella Saggiorato; Franco Noventa; Laura Trementino; Paolo Prandoni; Marco Boscaro; Giorgio Arnaldi; Carla Scaroni
Journal:  Endocrine       Date:  2015-06-26       Impact factor: 3.633

5.  Salivary cortisol results obtainable within minutes of sample collection correspond with traditional immunoassays.

Authors:  Elizabeth A Shirtcliff; Robert L Buck; Mary J Laughlin; Thomas Hart; Craig R Cole; Paul D Slowey
Journal:  Clin Ther       Date:  2015-03-12       Impact factor: 3.393

6.  Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Authors:  Rebecca R Klatzkin; Monica E Lindgren; Catherine A Forneris; Susan S Girdler
Journal:  Biol Psychol       Date:  2010-02-04       Impact factor: 3.251

7.  The CIRCORT database: Reference ranges and seasonal changes in diurnal salivary cortisol derived from a meta-dataset comprised of 15 field studies.

Authors:  Robert Miller; Tobias Stalder; Marc Jarczok; David M Almeida; Ellena Badrick; Meike Bartels; Dorret I Boomsma; Christopher L Coe; Marieke C J Dekker; Bonny Donzella; Joachim E Fischer; Megan R Gunnar; Meena Kumari; Florian Lederbogen; Christine Power; Carol D Ryff; S V Subramanian; Henning Tiemeier; Sarah E Watamura; Clemens Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2016-07-14       Impact factor: 4.905

Review 8.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

9.  Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study.

Authors:  Shannon L Gillespie; Cindy M Anderson; Songzhu Zhao; Yubo Tan; David Kline; Guy Brock; James Odei; Emily O'Brien; Mario Sims; Sophie A Lazarus; Darryl B Hood; Karen Patricia Williams; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2019-07-04       Impact factor: 4.905

Review 10.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.